Consolidated Balance Sheet (Unaudited) (USD $) In Millions	Sep. 30, 2011	Dec. 31, 2010
Current Assets
Cash and cash equivalents	$ 14,253	$ 10,900
Short-term investments	1,323	1,301
Accounts receivable (net of allowance for doubtful accounts of $129 in 2011 and $104 in 2010)	8,136	7,344
Inventories (excludes inventories of $1,382 in 2011 and $1,194 in 2010 classified in Other assets - see Note 6)	6,239	5,868
Deferred income taxes and other current assets	4,158	3,651
Total current assets	34,109	29,064
Investments	2,423	2,175
Property, Plant and Equipment, at cost, net of accumulated depreciation of $15,674 in 2011 and $13,481 in 2010	16,383	17,082
Goodwill	12,228	12,378
Other Intangibles, Net	35,822	39,456
Other Assets	5,569	5,626
Total Assets	106,534	105,781
Current Liabilities
Loans payable and current portion of long-term debt	2,455	2,400
Trade accounts payable	2,282	2,308
Accrued and other current liabilities	9,228	8,514
Income taxes payable	1,462	1,243
Dividends payable	1,166	1,176
Total current liabilities	16,593	15,641
Long-Term Debt	15,692	15,482
Deferred Income Taxes and Noncurrent Liabilities	16,653	17,853
Merck & Co., Inc. Stockholders' Equity
Common stock, $0.50 par value, Authorized - 6,500,000,000 shares, Issued - 3,576,948,356 shares in 2011 and 2010	1,788	1,788
Other paid-in capital	40,717	40,701
Retained earnings	38,763	37,536
Accumulated other comprehensive loss	(2,713)	(3,216)
Stockholders' equity before deduction for treasury stock	78,555	76,809
Less treasury stock, at cost 525,000,622 shares in 2011 and 494,841,533 shares in 2010	23,415	22,433
Total Merck & Co., Inc. stockholders' equity	55,140	54,376
Noncontrolling Interests	2,456	2,429
Total equity	57,596	56,805
Liabilities and Equity	$ 106,534	$ 105,781